Wang Qianyi
Ask VT AI
View News Summary
- Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
- Hamas hands over hostage remains as fragile ceasefire continues amid renewed violence
- Apple posts strong Q4 results, driven by robust iPhone 17 sales and growth in services business, despite supply shortages and regional disparities.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
- Hamas hands over hostage remains as fragile ceasefire continues amid renewed violence
- Apple posts strong Q4 results, driven by robust iPhone 17 sales and growth in services business, despite supply shortages and regional disparities.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Wang Qianyi
News from Wang Qianyi
